Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics

Molecular Psychiatry

Volumn 9, Issue 11, 2004, Pages 1042-1051

  Lee, J H ^a,b   Mayeux, R ^a,b,c   Mayo, D ^c,d   Mo, J ^c,d   Santana, V ^b   Williamson, J ^a,b   Flaquer, A ^a,b   Ciappa, A ^c   Rondon, H ^b,f   Estevez, P ^b   Lantigua, R ^a,c   Kawarai, T ^g   Toulina, A ^g   Medrano, M ^e   Torres, M ^f   Stern, Y ^a,b,c   Tycko, B ^a,c   Rogaeva, E ^g   St George Hyslop, P ^g   Knowles, J A ^a,c,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c Universidad Tecnologica de Santiago ^*  (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e UNIVERSIDAD TECNOLÓGICA DE SANTIAGO   (Dominican Republic)

^f Hospital General de la Plaza de la Salud   (Dominican Republic)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Genome scan; Linkage analysis

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARIBBEAN ISLANDS; CAUCASIAN; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 10Q; CHROMOSOME 12; CHROMOSOME 12P; CHROMOSOME 14; CHROMOSOME 18Q; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME MARKER; COHORT ANALYSIS; EUROPE; FAMILIAL DISEASE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC MARKER; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; NORTH AMERICA; PRIORITY JOURNAL; SIBLING;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CARIBBEAN REGION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 18; DOMINICAN REPUBLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISPANIC AMERICANS; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; NEW YORK; PEDIGREE; PUERTO RICO;

EID: 4444253260     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001538     Document Type: Article

References (51)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
2. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 1998; 55: 964-968.
3. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I et al. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 1999; 8: 237-245.
4. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L et al. Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 2000; 35: 1343-1352.
5. Wu WS, Holmans P, Wavrant-DeVrieze F, Shears S, Kehoe P, Crook R et al. Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 1998; 280: 619-622.
6. Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 2000; 290: 2304-2305.
7. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J et al. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 2000; 290: 2303-2304.
8. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000; 290: 2302-2303.
9. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997; 278: 1237-1241.
10. Rogaeva E, Premkumar S, Song Y, Sorbi S, Brindle N, Paterson A et al. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 1998; 280: 614-618.
11. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001; 56: 49-56.
12. Maestre G, Ottman R, Stern Y, Gurland B, Chun M, Tang MX et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995; 37: 254-259.
13. Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998; 279: 751-755.
14. Romas SN, Santana V, Williamson J, Ciappa A, Lee JH, Rondon HZ et al. Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch Neurol 2002; 59: 87-91.
15. Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH et al. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA 2001; 286: 2257-2263.
16. Mayeux R, Lee JH, Romas SN, Mayo D, Santana V, Williamson J et al. Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am J Hum Genet 2002; 70: 237-243.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the department of health and human services task force on Alzheimer's disease. Neurology 1984; 34: 939-944.
18. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
19. Pittman J, Andrews H, Tatemichi T, Link B, Struening E, Stern Y et al. Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis. Arch Neurol 1992; 49: 461-467.
20. Stern Y, Andrews H, Pittman J, Sano M, Tatemichi T, Lantigua R et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992; 49: 453-460.
21. Stricks L, Pittman J, Jacobs DM, Sano M, Stern Y. Normative data for a brief neuropsychological battery administered to English- and Spanish-speaking community-dwelling elders. J Int Neuropsychol Soc 1998; 4: 311-318.
22. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
23. Adams P. LABMAN and LINKMAN: a data management system specifically designed for genome searches of complex diseases. Genet Epidemiol 1994; 11: 87-98.
24. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL. Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 1998; 63: 861-869.
25. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
26. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
27. Goring HH, Ott J. Relationship estimation in affected sib pair analysis of late-onset diseases. Eur J Hum Genet 1997; 5: 69-77.
28. Goring HH, Terwilliger JD. Linkage analysis in the presence of errors III: marker loci and their map as nuisance parameters. Am J Hum Genet 2000; 66: 1298-1309.
29. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-1363.
30. Terwilliger JD, Ott J. Handbook of Human Genetic Linkage. The Johns Hopkins University Press: Baltimore, 1994.
31. Ott J. Strategies for characterizing highly polymorphic markers in human gene mapping. Am J Hum Genet 1992; 51: 283-290.
32. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet 1998; 62: 450-458.
33. Goring HH, Terwilliger JD. Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified. Am J Hum Genet 2000; 66: 1310-1327.
34. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 2002; 70: 985-993.
35. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 2003; 12: 3259-3267.
36. Scott WK, Grubber JM, Conneally PM, Small GW, Hulette CM, Rosenberg CK et al. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am J Hum Genet 2000; 66: 922-932.
37. Olson JM, Goddard KA, Dudek DM. A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet 2002; 71: 154-161.
38. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003; 12: 23-32.
39. Farrer LA, Bowirrat A, Friedland RP, Waraska K, Korczyn AD, Baldwin CT. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet 2003; 12: 415-422.
40. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
41. Scott WK, Grubber JM, Abou-Donia SM, Church TD, Saunders AM, Roses AD et al. Further evidence linking late-onset Alzheimer disease with chromosome 12. JAMA 1999; 281: 513-514.
42. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998; 19: 357-360.
43. Dodel RC, Du Y, Bales KR, Gao F, Eastwood B, Glazier B et al. Alpha2 macroglobulin and the risk of Alzheimer's disease. Neurology 2000; 54: 438-442.
44. Wavrant-DeVrieze F, Perez-Tur J, Lambert JC, Frigard B, Pasquier F, Delacourte A et al. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 1997; 227: 68-70.
45. Martin-Rehrmann MD, Cho HS, Rebeck GW. Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease. Neurosci Lett 2002; 328: 109-112.
46. Saunders AJ, Bertram L, Mullin K, Sampson AJ, Latifzai K, Basu S et al. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Hum Mol Genet 2003; 12: 2765-2776.
47. Suarez BK, Hampe CL, Van Eerdewegh P. Problems of replicating linkage claims in psychiatry. In: Gershon ES, Cloninger CR (eds) Genetic Approaches to Mental Disorders. American Psychiatric Press, Inc: Washington, DC, 1994 pp 23-46.
48. Roberts SB, MacLean CJ, Neale MC, Eaves LJ, Kendler KS. Replication of linkage studies of complex traits: an examination of variation in location estimates. Am J Hum Genet 1999; 65: 876-884.
49. Ait-Ghezala G, Abdullah L, Crescentini R, Crawford F, Town T, Singh S et al. Confirmation of association between D10S583 and Alzheimer's disease in a case-control sample. Neurosci Lett 2002; 325: 87-90.
50. Abraham R, Myers A, Wavrant-DeVrieze F, Hamshere ML, Thomas HV, Marshall H et al. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 2001; 109: 646-652.
51. Ertekin-Taner N, Ronald J, Asahara H, Younkin L, Hella M, Jain S et al. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigress. Hum Mol Genet 2003; 12: 3133-3143.